Saltar al contenido
Merck

Extensive lichenoid drug eruption due to glyburide: a case report and review of the literature.

Cutis (2005-09-08)
Gary N Fox, Colleen C Harrell, Darius R Mehregan
RESUMEN

Lichenoid reactions to sulfonylurea drugs have been reported, albeit infrequently. To our knowledge, this is the first case of a generalized lichenoid dermatitis likely induced by the third-generation sulfonylurea hypoglycemic drug glyburide.

MATERIALES
Número de producto
Marca
Descripción del producto

Supelco
Glyburide (Glibenclamide), Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glybenclamide, ≥99% (HPLC)
Sigma-Aldrich
Glyburide, meets USP testing specifications
Glibenclamide for peak identification, European Pharmacopoeia (EP) Reference Standard
Glybenclamide, European Pharmacopoeia (EP) Reference Standard